Literature DB >> 31130826

Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications.

Patrick J McCormick1.   

Abstract

PURPOSE OF REVIEW: This review discusses global trends in cancer mortality and survival, the socioeconomic drivers of those trends, and recent innovations in cancer surgery. RECENT
FINDINGS: Cancer is a leading cause of death worldwide. Cancer, previously a disease primarily of wealthy countries, is rapidly becoming a leading cause of death in low- and middle-income countries. Major economic forces driving global cancer trends include aging, frailty, and obesity. Alcohol consumption, poor diet, and lack of exercise also contribute to cancer types associated with modifiable causes. Surgery is responsible for 65% of cancer care globally, providing an opportunity for anesthesiologists to improve that care. Anesthesiologists can contribute to cancer remission through perioperative interventions that reduce risk of metastasis and speed return to intended oncologic therapy.
SUMMARY: Cancer surgery comprises a large proportion of anesthetic caseload. Good outcomes come from high volume cancer centers using a multidisciplinary approach.

Entities:  

Keywords:  anesthesia; cancer; global surgery; perioperative medicine; postoperative complications; return to intended oncologic therapy

Year:  2018        PMID: 31130826      PMCID: PMC6530937          DOI: 10.1007/s40140-018-0294-1

Source DB:  PubMed          Journal:  Curr Anesthesiol Rep        ISSN: 1523-3855


  34 in total

1.  International variation in prostate cancer incidence and mortality rates.

Authors:  Melissa M Center; Ahmedin Jemal; Joannie Lortet-Tieulent; Elizabeth Ward; Jacques Ferlay; Otis Brawley; Freddie Bray
Journal:  Eur Urol       Date:  2012-03-08       Impact factor: 20.096

2.  Anesthetic management and one-year mortality after noncardiac surgery.

Authors:  Terri G Monk; Vikas Saini; B Craig Weldon; Jeffrey C Sigl
Journal:  Anesth Analg       Date:  2005-01       Impact factor: 5.108

3.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

4.  Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival.

Authors:  Sarah E Tevis; Brittney M Kohlnhofer; Sarah Stringfield; Eugene F Foley; Bruce A Harms; Charles P Heise; Gregory D Kennedy
Journal:  Dis Colon Rectum       Date:  2013-12       Impact factor: 4.585

5.  Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.

Authors:  Thomas A Aloia; Giuseppe Zimmitti; Claudius Conrad; Vijaya Gottumukalla; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Surg Oncol       Date:  2014-05-21       Impact factor: 3.454

6.  Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus.

Authors:  Guillaume Luc; Marlène Durand; Laurence Chiche; Denis Collet
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

7.  Smoking prevalence and cigarette consumption in 187 countries, 1980-2012.

Authors:  Marie Ng; Michael K Freeman; Thomas D Fleming; Margaret Robinson; Laura Dwyer-Lindgren; Blake Thomson; Alexandra Wollum; Ella Sanman; Sarah Wulf; Alan D Lopez; Christopher J L Murray; Emmanuela Gakidou
Journal:  JAMA       Date:  2014-01-08       Impact factor: 56.272

8.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

9.  Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease.

Authors:  Maj-Lis Lindholm; Stefan Träff; Fredrik Granath; Scott D Greenwald; Anders Ekbom; Claes Lennmarken; Rolf H Sandin
Journal:  Anesth Analg       Date:  2009-02       Impact factor: 5.108

10.  The role of surgery in global health: analysis of United States inpatient procedure frequency by condition using the Global Burden of Disease 2010 framework.

Authors:  John Rose; David C Chang; Thomas G Weiser; Nicholas J Kassebaum; Stephen W Bickler
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

View more
  4 in total

1.  Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries.

Authors:  Alice Pisana; Björn Wettermark; Amanj Kurdi; Biljana Tubic; Caridad Pontes; Corinne Zara; Eric Van Ganse; Guenka Petrova; Ileana Mardare; Jurij Fürst; Marta Roig-Izquierdo; Oyvind Melien; Patricia Vella Bonanno; Rita Banzi; Vanda Marković-Peković; Zornitsa Mitkova; Brian Godman
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 2.  Cancers: What Are the Costs in Relation to Disability-Adjusted Life Years? A Systematic Review and Meta-Analysis.

Authors:  Jacopo Garlasco; Mario Cesare Nurchis; Valerio Bordino; Martina Sapienza; Gerardo Altamura; Gianfranco Damiani; Maria Michela Gianino
Journal:  Int J Environ Res Public Health       Date:  2022-04-16       Impact factor: 4.614

Review 3.  Current Evidence of the Role of the Myokine Irisin in Cancer.

Authors:  Evangelia Tsiani; Nicole Tsakiridis; Rozalia Kouvelioti; Alina Jaglanian; Panagiota Klentrou
Journal:  Cancers (Basel)       Date:  2021-05-27       Impact factor: 6.639

4.  Cancer Biology, Epidemiology, and Treatment in the 21st Century: Current Status and Future Challenges From a Biomedical Perspective.

Authors:  Patricia Piña-Sánchez; Antonieta Chávez-González; Martha Ruiz-Tachiquín; Eduardo Vadillo; Alberto Monroy-García; Juan José Montesinos; Rocío Grajales; Marcos Gutiérrez de la Barrera; Hector Mayani
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.